In vitro anticancer effects of a marine-derived glycosaminoglycan-containing extract from Dicentrarchus labrax scales on human glioblastoma cells
Abstract
Background: Marine ecosystems are an underexplored source of structurally diverse bioactive compounds with therapeutic potential. Among these, glycosaminoglycans (GAGs) have gained attention for their anticoagulant, antioxidant, anti-inflammatory, and antitumor properties. Glioblastoma, the most aggressive malignant primary brain tumor in adults, remains largely incurable due to its high invasiveness, therapeutic resistance, and the protective blood–brain barrier. Therefore, the ongoing need to identify new treatment candidates persists.
Aims: This study aimed to investigate the potential anticancer effects of Dicentrarchus labrax (European seabass) scale extract (DLSE) on human glioblastoma U-87MG cells.
Methods: GAG-containing extracts were prepared from fish scales, and their chemical structures were characterized using Fourier-transform infrared (FTIR) spectroscopy. Cell viability was determined by the MTT assay, migration by scratch wound-healing assay, apoptosis by Hoechst/PI staining, and molecular changes by immunoblotting.
Results: FTIR analysis confirmed the key functional groups consistent with a GAG-like polysaccharide profile. DLSE reduced cell viability in a dose- and time-dependent manner, with an IC50 value of 993 μg/mL at 72 hours. Treatments with 600 and 1000 μg/mL DLSE for 72 hours inhibited cell migration, induced apoptosis, increased the Bax/Bcl-2 ratio, and elevated levels of cleaved caspase-3 and PARP1. DLSE also activated p53/p21-mediated cell-cycle regulatory pathways, and induced ER stress through dose-dependent increases in Grp78, PERK, IRE1α, and cleaved ATF6 levels.
Conclusion: Our findings indicate that GAG-containing DLSE stimulates multiple antitumor pathways in glioblastoma cells. Although further in vivo research and compound fractionation are necessary, marine-derived GAG-rich extracts could be promising adjuncts for glioblastoma therapy.
Keywords
Supporting Institution
Project Number
Ethical Statement
References
- Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012). Glycosaminoglycans: key players in cancer cell biology and treatment. The FEBS Journal 279(7), 1177–1197. https://doi.org/10.1111/j.1742-4658.2012.08529.x Aksüt, Y., Şengelen, A., Gürsoy, D. M., Öğütcü, İ., Kuvet, Ö., & Pekmez, M. (2025). Chrysin sensitizes glioblastoma cells and spheroids to temozolomide treatment by reducing EMT and stemness phenotypes, as well as targeting multidrug resistance proteins. Frontiers in pharmacology, 16, 1643186. https://doi.org/10.3389/fphar.2025.1643186
- Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020). The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nature Reviews Cancer, 20(1), 26–41. https://doi.org/10.1038/s41568-019-0205-x
- Atashrazm, F., Lowenthal, R. M., Woods, G. M., Holloway, A. F., & Dickinson, J. L. (2015). Fucoidan and cancer: a multifunctional molecule with anti-tumor potential. Marine drugs, 13(4), 2327–2346. https://doi.org/10.3390/md13042327
- Augusto, A., Lemos, M. F. L., & Silva, S. F. J. (2024). Exploring Marine-Based Food Production: The Challenges for a Sustainable and Fast Biotechnology-Based Development. Applied Sciences, 14(18), 8255. https://doi.org/10.3390/app14188255
- Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
- Brézillon, S., Untereiner, V., Lovergne, L., Tadeo, I., Noguera, R., Maquart, F. X., Wegrowski, Y., & Sockalingum, G. D. (2014). Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging. Analytical and bioanalytical chemistry, 406(24), 5795–5803. https://doi.org/10.1007/s00216-014-7994-2
- Cabral, E. M., Mondala, J. R. M., Oliveira, M., Przyborska, J., Fitzpatrick, S., Rai, D. K., Sivagnanam, S. P., Garcia-Vaquero, M., O'Shea, D., Devereux, M., Tiwari, B. K., & Curtin, J. (2021). Influence of molecular weight fractionation on the antimicrobial and anticancer properties of a fucoidan rich-extract from the macroalgae Fucus vesiculosus. International journal of biological macromolecules, 186, 994–1002. https://doi.org/10.1016/j.ijbiomac.2021.06.182
- Carrasqueira, J., Bernardino, S., Bernardino, R., & Afonso, C. (2025). Marine-Derived Polysaccharides and Their Potential Health Benefits in Nutraceutical Applications. Marine drugs, 23(2). https://doi.org/10.3390/md23020060
Details
Primary Language
English
Subjects
Glycobiology
Journal Section
Research Article
Authors
Yunus Aksüt
0000-0001-9407-5019
Türkiye
Nebahat Buşra Aksoy
This is me
0009-0003-1931-3058
Türkiye
Aslıhan Şengelen
0000-0003-2512-319X
Türkiye
Eren Yıldırım
0000-0002-7924-9698
Türkiye
Emre Yemişken
0000-0002-7738-5936
Türkiye
Murat Pekmez
0000-0002-6150-8372
Türkiye
Early Pub Date
June 12, 2026
Publication Date
-
Submission Date
March 26, 2026
Acceptance Date
June 6, 2026
Published in Issue
Year 2026 Number: Advanced Online Publication
